학술논문
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study
Document Type
Article
Author
Fizazi, Karim ; Kramer, Gero; Eymard, Jean-Christophe; Sternberg, Cora N; de Bono, Johann; Castellano, Daniel; Tombal, Bertrand; Wülfing, Christian; Liontos, Michael; Carles, Joan; Iacovelli, Roberto; Melichar, Bohuslav; Sverrisdóttir, Ásgerður; Theodore, Christine; Feyerabend, Susan; Helissey, Carole; Oudard, Stéphane; Facchini, Gaetano; Poole, Elizabeth M; Ozatilgan, Ayse; Geffriaud-Ricouard, Christine; Bensfia, Samira; de Wit, Ronald
Source
In The Lancet Oncology November 2020 21(11):1513-1525
Subject
Language
ISSN
1470-2045